Oncology

1 drug is in development for Squamous Cell Carcinoma.

Companies: 1
Clinical trials: 13

BioSniper AIPage evidence connected

Prepared research question

Which programs lead the Squamous Cell Carcinoma pipeline—and what evidence could change the picture?

Run cited research

Traceable citations · Unknowns marked

Drug Pipeline by Phase

Phase 1/Phase 2(1)

Drug	Company
neo212	NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)

About this indication

Squamous Cell Carcinoma context

Oncology·MeSH: Carcinoma, Squamous Cell (D002294)

Also known as: Carcinomas, Epidermoid, Carcinomas, Planocellular, Carcinomas, Squamous, Carcinomas, Squamous Cell, Epidermoid Carcinoma, Planocellular Carcinoma, Squamous Carcinoma

Prevalence

14.0 / 100K

Incidence

6.0 / 100K/yr

Frequently asked questions

How many drugs are in development for Squamous Cell Carcinoma?

BioSniper tracks 1 drug in development for Squamous Cell Carcinoma across 1 company.

How many clinical trials target Squamous Cell Carcinoma?

There are 13 clinical trials targeting Squamous Cell Carcinoma tracked by BioSniper.

What is the prevalence of Squamous Cell Carcinoma?

The estimated prevalence of Squamous Cell Carcinoma is approximately 14.0 per 100,000 population.